P < .05). For patients undergoing CAS, patency of the external carotid artery (odds ratio [OR],]; P ¼ .04), lesion calcification (OR,]; P ¼ .04), and lesion length (OR,]; P ¼ .05) were all found to be independent risk factors for postoperative embolization. These factors did not confer increased risk to patients undergoing CEA.
Objective: Frailty is increasingly recognized as a key determinate in predicting postoperative outcomes. Centers may see patients who are more frail, potentially accounting for poorer outcomes in hospital comparisons that may not be captured in risk adjustment. We aimed to evaluate the variability in frailty burden among centers in the Vascular Quality Initiative database and to determine the effect of frailty on long-term mortality in patients undergoing abdominal aortic aneurysm (AAA) repair.
Methods:
Patients undergoing open and endovascular AAA repair (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) were identified. Patients with complete data on component variables of the validated Risk Analysis Index (RAI) and centers with >10 AAA repairs were included. Vascular Quality Initiative RAI characteristics are sex, age, body mass index, renal failure, congestive heart failure, dyspnea, preoperative ambulation, functional status, and mental status. Frailty was defined as the top 10% of RAI scores (RAI $37). Center-level RAI differences were assessed by global F test of center ID fixed effects in linear regression. The relationship between patient frailty and survival was evaluated by hierarchical Cox proportional hazards regression with random intercept for center, controlling for race, insurance, AAA diameter, AAA case mix, and year.
Results: A total of 20,657 patients with complete records from 190 centers were included. RAI scores ranged from 3 to 63 (mean, 28; standard deviation, 6.3). RAI varied significantly across centers, with center mean range of 22.6 to 31.8 and percentage of frail patients range of 0% to 31.3% (F test, P < .001; Fig 1) . In Kaplan-Meier analysis, frailty was associated with poor survival (P < .001; Fig 2) , and most of the risk varied in the first postoperative year. Frailty was independently associated with long-term mortality (hazard ratio, 3.0; 95% confidence interval, 2.7-3.3) after accounting for center-level variance.
Conclusions: There is considerable variability of preoperative frailty in AAA patients among centers. Adjusting for center-level variation in frailty burden, frailty still had a significant association with long-term mortality. Routine measurement of frailty preoperatively by centers to identify highrisk patients and implementation of perioperative interventions may help mitigate procedural and long-term mortality and improve shared decision-making regarding AAA repair.
Author Disclosures: E. L. George: Nothing to disclose; K. Blum: Nothing to disclose; A. W. Trickey: Nothing to disclose; B. Brooke: Nothing to disclose; L. Kraiss: Nothing to disclose; M. W. Mell: Nothing to disclose; P. Goodney: Nothing to disclose; J. Johanning: Nothing to disclose; J. Hockenberry: Nothing to disclose; S. Arya: Nothing to disclose. Objective: The creation of an arteriovenous fistula (AVF) for hemodialysis access is a low-risk procedure. It is often time sensitive, as avoidance of central venous catheters (CVCs) and their complications is paramount. Thus, the role of preanesthesia testing (PAT) is debatable, particularly if it delays surgery for further workup. We sought to determine the value and potential adverse impact of PAT.
Preoperative Testing Among Patients Undergoing Arteriovenous Fistula Surgery
Methods: A retrospective analysis was conducted of all AVF patients who had a delay in AVF surgery by PAT for further workup compared with a randomly selected group of patients who were not delayed. Patients were tracked daily from the day of PAT for 6 months. Main outcome measures were need for CVC intervention, emergency department (ED) visits for dialysis-related reasons, and hospital visits for consultations or diagnostics.
Results: There were 51 patients who had AVF delayed by PAT and 73 patients without delay. There was no significant difference between delayed and nondelayed groups in comparing age (P ¼ .65), sex (P ¼ .33), American Society of Anesthesiologists classification (median of 3 for both; P ¼ .42), Revised Cardiac Risk Index (median score of 2 for both; P ¼ .12), or prevalence of CVC for hemodialysis at time of PAT (62% vs 72%; P ¼ .25). In the delayed group, the median time from initial PAT evaluation to surgery was 90 days. Only 3 of 51 (5.88%) of the surgery delay group had a documented medical finding that prompted a change in management. In the 6 months after initial PAT, the delayed surgery group had a significantly higher average number of ED visits (0.47 vs 0.03; P < .001), need for new or replaced CVC (31.9% vs 1.37%; P < .001), and increase in general hospital visits (2.74 vs 0.34; P < .001) .  Fig 1. Variation across centers in mean Risk Analysis Index (RAI) score. 
